These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3284276)

  • 21. Evaluation of tear break-up time, Schirmer's-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca.
    Paschides CA; Kitsios G; Karakostas KX; Psillas C; Moutsopoulos HM
    Clin Exp Rheumatol; 1989; 7(2):155-7. PubMed ID: 2736828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis.
    Hill JC
    Br J Ophthalmol; 1989 Feb; 73(2):151-4. PubMed ID: 2649149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratoconjunctivitis sicca in rheumatoid arthritis.
    Mody GM; Hill JC; Meyers OL
    Clin Rheumatol; 1988 Jun; 7(2):237-41. PubMed ID: 3262029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen's syndrome].
    Safonova TN; Gladkova OV; Boev VI
    Vestn Oftalmol; 2019; 135(1):59-66. PubMed ID: 30830076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term followup of patients with Sjögren's syndrome.
    Kruize AA; Hené RJ; van der Heide A; Bodeutsch C; de Wilde PC; van Bijsterveld OP; de Jong J; Feltkamp TE; Kater L; Bijlsma JW
    Arthritis Rheum; 1996 Feb; 39(2):297-303. PubMed ID: 8849383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome.
    Ramos-Remus C; Suarez-Almazor M; Russell AS
    Clin Exp Rheumatol; 1994; 12(4):375-80. PubMed ID: 7955600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
    Stern ME; Gao J; Schwalb TA; Ngo M; Tieu DD; Chan CC; Reis BL; Whitcup SM; Thompson D; Smith JA
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2609-14. PubMed ID: 12147592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratoconjunctivitis sicca.
    Roberts DK
    J Am Optom Assoc; 1991 Mar; 62(3):187-99. PubMed ID: 1813522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beneficial effect of the local application of plasma fibronectin and autologous serum in patients with the keratoconjunctivitis sicca of Sjögren's syndrome].
    Kono I; Kono K; Narushima K; Akama T; Suzuki H; Yamane K; Kashiwagi H
    Ryumachi; 1986 Oct; 26(5):339-43. PubMed ID: 3603237
    [No Abstract]   [Full Text] [Related]  

  • 32. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical study of slow-releasing artificial tears.
    Lamberts DW; Langston DP; Chu W
    Ophthalmology; 1978 Aug; 85(8):794-800. PubMed ID: 714380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
    Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H
    Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lacrimal gland accumulation of 67Ga-citrate in patients with Sjögren's syndrome.
    Tanabe M; Hasegawa E; Matsuo N; Tamai T; Satoh K; Kojima K; Sato C; Murakami TH
    Eur J Nucl Med; 1984; 9(5):233-6. PubMed ID: 6587966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of Sjögren's sicca complex in a population of patients with keratoconjunctivitis sicca.
    Forstot JZ; Forstot SL; Greer RO; Tan EM
    Arthritis Rheum; 1982 Feb; 25(2):156-60. PubMed ID: 7066046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rose bengal staining of the temporal conjunctiva differentiates Sjögren's syndrome from keratoconjunctivitis sicca.
    Caffery B; Simpson T; Wang S; Bailey D; McComb J; Rutka J; Slomovic A; Bookman A
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2381-7. PubMed ID: 20107179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of human tear proteins--2. Analysis by crossed immunoelectrophoresis of tears from diseased eyes.
    Inada K; Baba H; Okamura R
    Jpn J Ophthalmol; 1983; 27(2):277-88. PubMed ID: 6620714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.
    Uhlig T; Kvien TK; Jensen JL; Axéll T
    Ann Rheum Dis; 1999 Jul; 58(7):415-22. PubMed ID: 10381485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.